128 related articles for article (PubMed ID: 37003369)
1. Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
Jahreiß MC; Hoogeman M; Aben KK; Dirkx M; Snieders R; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; Incrocci L; Heemsbergen WD
Radiother Oncol; 2023 Jun; 183():109659. PubMed ID: 37003369
[TBL] [Abstract][Full Text] [Related]
2. Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study.
Jahreiß MC; Heemsbergen WD; van Santvoort B; Hoogeman M; Dirkx M; Pos FJ; Janssen T; Dekker A; Vanneste B; Minken A; Hoekstra C; Smeenk RJ; van Oort IM; Bangma CH; Incrocci L; Aben KKH
Front Oncol; 2021; 11():771956. PubMed ID: 34900722
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
4. Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.
Jahreiß MC; Heemsbergen WD; Janus C; van de Pol M; Dirkx M; Dinmohamed AG; Nout RA; Hoogeman M; Incrocci L; Aben KKH
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e278-e288. PubMed ID: 36725405
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric analysis of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy-step and shoot, helical tomotherapy, and volumetric modulated arc therapy in prostate cancer radiotherapy.
Gozal F; Gondhowiardjo SA; Kodrat H; Wibowo WE
J Cancer Res Ther; 2021; 17(4):893-900. PubMed ID: 34528538
[TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
7. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
Wong WW; Vora SA; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
Cancer; 2009 Dec; 115(23):5596-606. PubMed ID: 19670452
[TBL] [Abstract][Full Text] [Related]
8. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
9. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
10. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors.
Buwenge M; Scirocco E; Deodato F; Macchia G; Ntreta M; Bisello S; Siepe G; Cilla S; Alitto AR; Valentini V; Strigari L; Morganti AG; Cammelli S
BMC Cancer; 2020 Feb; 20(1):90. PubMed ID: 32013912
[TBL] [Abstract][Full Text] [Related]
12. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
14. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
15. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
16. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
17. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.
Abo-Madyan Y; Aziz MH; Aly MM; Schneider F; Sperk E; Clausen S; Giordano FA; Herskind C; Steil V; Wenz F; Glatting G
Radiother Oncol; 2014 Mar; 110(3):471-6. PubMed ID: 24444525
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
19. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.
Palma D; Vollans E; James K; Nakano S; Moiseenko V; Shaffer R; McKenzie M; Morris J; Otto K
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):996-1001. PubMed ID: 18455326
[TBL] [Abstract][Full Text] [Related]
20. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
